These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 15648547)
1. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties. Wiesli P; Schmid C; Perren A; Pfammatter T; Spinas GA; Keller U J Endocrinol Invest; 2004 Oct; 27(9):832-8. PubMed ID: 15648547 [TBL] [Abstract][Full Text] [Related]
2. Insulinoma in a patient with normal results from prolonged fast and glucagon-induced hypoglycemia. Soh AW; Kek PC Endocr Pract; 2010; 16(5):838-41. PubMed ID: 20570814 [TBL] [Abstract][Full Text] [Related]
4. Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations. Wiesli P; Brändle M; Schmid C; Krähenbühl L; Furrer J; Keller U; Spinas GA; Pfammatter T J Vasc Interv Radiol; 2004 Nov; 15(11):1251-6. PubMed ID: 15525744 [TBL] [Abstract][Full Text] [Related]
5. Asymptomatic insulinoma: a case report and autopsy series. Kishi S; Sakamoto K; Mori M; Isogawa A; Shiba T Diabetes Res Clin Pract; 2012 Dec; 98(3):445-51. PubMed ID: 23084041 [TBL] [Abstract][Full Text] [Related]
6. Insulin responses to selective arterial calcium infusion under hyperinsulinemic euglycemic glucose clamps: case studies in adult nesidioblastosis and childhood insulinoma. Nakagawa A; Ueno K; Ito M; Okamoto S; Uehara K; Ito H; Mishina S; Kinoshita E; Nojima T; Takahashi H; Ikawa H; Takashima S; Nishizawa M; Nakano S; Kigoshi T; Nakabayashi H; Uchida K Endocr J; 2007 Feb; 54(1):27-33. PubMed ID: 17053293 [TBL] [Abstract][Full Text] [Related]
7. Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells. Won JG; Tseng HS; Yang AH; Tang KT; Jap TS; Kwok CF; Lee CH; Lin HD Metabolism; 2003 Oct; 52(10):1320-9. PubMed ID: 14564685 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas. Nauck MA; Meier JJ Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin. Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168 [TBL] [Abstract][Full Text] [Related]
11. Forty-eight-hour fast: the diagnostic test for insulinoma. Hirshberg B; Livi A; Bartlett DL; Libutti SK; Alexander HR; Doppman JL; Skarulis MC; Gorden P J Clin Endocrinol Metab; 2000 Sep; 85(9):3222-6. PubMed ID: 10999812 [TBL] [Abstract][Full Text] [Related]
12. Concurrent insulinoma and impaired glucose tolerance suspected as owing to obesity. Iizuka K; Fujisawa T; Takeda J BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26729835 [TBL] [Abstract][Full Text] [Related]
13. Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin. Hamano K; Akita K; Takeuchi Y; Suwa T; Takeda J; Dodo S Intern Med; 2019 Dec; 58(24):3563-3568. PubMed ID: 31462593 [TBL] [Abstract][Full Text] [Related]
14. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma. Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303 [TBL] [Abstract][Full Text] [Related]
15. Qualitative abnormality of insulin secretion in a case with insulinoma. Harano Y; Kohama M; Araki N; Sakamoto A; Hoshi M Endocrinol Jpn; 1975 Apr; 22(2):175-80. PubMed ID: 168060 [TBL] [Abstract][Full Text] [Related]
16. Glucose counterregulatory hormones in the 72-hour fast. Vella A; Service FJ; O'Brien PC Endocr Pract; 2003; 9(2):115-8. PubMed ID: 12917072 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of insulin secretion patterns in insulinoma. Saddig C; Goretzki PE; Starke AA World J Surg; 2008 May; 32(5):918-29. PubMed ID: 18259806 [TBL] [Abstract][Full Text] [Related]
18. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma. Pun KK; Young RT; Wang C; Tam CF; Ho PW J Clin Endocrinol Metab; 1988 Sep; 67(3):546-50. PubMed ID: 2842361 [TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes. Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327 [TBL] [Abstract][Full Text] [Related]
20. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Hoff AO; Vassilopoulou-Sellin R Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]